eGenesis strives to create a world
with no shortage of human transplantable organs
Organ transplantation is currently failing to meet critical patient needs due to a massive gap between organ demand and supply globally.
As leaders in gene editing and genome engineering, we are uniquely positioned to address the organ crisis with our unparalleled, multiplexed gene editing platform.
We are driven to provide hope to thousands of patients with end-stage organ disease by providing an alternative source of safe and effective human-compatible organs.
Gene Engineering
Single Cell Cloning
Somatic Cell Nuclear / Embryo Transfer
Organ Procurement
Transplantation
Latest News
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.
eGenesis New York Office
7 Times Sq.
43rd Floor
New York, NY 10036